CRF Health announced that its TrialMax Touch solution has been selected for a landmark global oncology trial. The trial will involve more than 1,000 patients across 200 sites in 20 countries and provide a version of TrialMax solution to all involved. Not only does this solution increase insightOriginal Article
You may also like
New alloys for manufacturing freeze-dryers
Navigating the Complexities of Emerging Therapy...
INTERPHEX 2025: Preventing Spills in the Manufacturing...
Agentic AI Growth Predicted, but More Than Half of...
Microsoft and SkyCell Collaborate on Pharma Supply...
Siemens Acquires Dotmatics, Extending AI Software...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.